Epstein Secrets

ent ID: AddreSS:a EAST 71ST STREET, NEW YORK, NY 10021 P: 1.37 >0.1 "This test was developed and its performance characteristics determined by Viracor Eurofins. It has not been cleared or approved by the O.S. Food and • Drug Administration. ' Testing Performed At: Viracor Eurofins 1001 NW Technology Driv

n this assay. --Test developed and characteristics determined by OUP --Laboratories. See Compliance Statement 4: aruplab.com/CS --www.aruplab,com, Julio Delgado, MD - Lab. Director QUINTANA Affdik (30) SEE BELOW B. quintana Ab, IgM < 1:16 --INTERPRETIVE INFORMATION: Bartonella quintana Ab, Ism -- Less t

NW Technology Drive Lee's Siltrit, MO 64086 (see) 385-5198 CLIAlt 26O-0983643 Tetanus Antibody IgG (58) • . . . "This test was developed and Viracor Eurofins. It has not : Drug Administration. ' Testing Performed At: • Viracor Eurofins 1001 Nw Technology Drive Lee'sSummit MO 64086 ILIJIIIIIii 20D-09

n this assay. --Test developed and characteristics determined by OUP --Laboratories. See Compliance Statement 4: aruplab.com/CS --www.aruplab,com, Julio Delgado, MD - Lab. Director QUINTANA Affdik (30) SEE BELOW B. quintana Ab, IgM < 1:16 --INTERPRETIVE INFORMATION: Bartonella quintana Ab, Ism -- Less t

• • •• • ••••••It • i• "41.1 • '•• ••• ••'• .•'•• • " I Viracor EurofinS. It as no, teen clear? or . Drug Administration. Testing Performed At: Viracor Eurofins 1001 NW Technology Drive . Lee's Summit, MO 64886 IIIMMESI CLIM 643 e.11eitflfliekid Ab (3) piiieriieile l`gM Ab (3) <1:20 aPPrOve 1:64 • •

t-infection. --Test developed and characteristics determined by ARUP --Laboratories. See Compliance Statement A: aruplab.com/CS --www.aruplab.com, Julio Delgado, MD - Lab. Director B. quintana Ab, Ig6 <1:64 --INTERPRETIVE INFORMATION: ilartonella quintana Antibody, IgG -- Less than 1:64 Negative: No si